Business
Fortress Biotech to Participate in the H.C. Wainwright 1st Annual Royalty Company Virtual Conference
MIAMI, May 07, 2025 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings and dividend and royalty revenue, today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will participate in the following sessions at the H.C. Wainwright 1st Annual Royalty Company Virtual Conferen
About this update from Fortress Biotech, Inc.
[{"type":"image","alt":"Fortress Biotech, Inc.","displaySize":"","headline":null,"caption":"Fortress Biotech, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":228,"url":"https://media.zenfs.com/en/globenewswire.com/67d8842b1a3f40249dd9679548ed4862"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/3_0qSM501xaK8lgQjQGDIA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTMxOTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/67d8842b1a3f40249dd9679548ed4862","width":300,"height":228}},"lazy":false},{"type":"text","content":"MIAMI, May 07, 2025 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings and dividend and royalty revenue, today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will participate in the following sessions at the H.C. Wainwright 1st Annual Royalty Company Virtual Conference, taking place on Tuesday, May 13, 2025:","length":542,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"2:00 p.m. – 2:30 p.m. ET: Fireside Chat","length":39,"tagName":"p"}]},{"val":[{"type":"text","content":"5:00 p.m. – 6:00 p.m. ET: Panel Presentation: Development Stage Companies – Where Do Royalty and Tech Platform Plays Fit?","length":121,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":160,"olType":false},{"type":"text","content":"To register for the conference, visit https://hcwevents.com/royalty-company-conference.","length":87,"tagName":"p"},{"type":"text","content":"About Fortress BiotechFortress Biotech, Inc. (“Fortress”) is an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings and dividend and royalty revenue. The company has eight marketed prescription pharmaceutical products and over 20 programs in development at Fortress, at its majority-owned and majority-controlled partners and subsidiaries and at partners and subsidiaries it founded and in which it holds significant minority ownership positions. Fortress’ portfolio is being commercialized and developed for various therapeutic areas including oncology, dermatology, and rare diseases. Fortress’ model...